Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries

Published:2015-01 Issue:1 Volume:193 Page:80-86
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Haider Ahmad¹,Zitzmann Michael²,Doros Gheorghe³,Isbarn Hendrik⁴,Hammerer Peter⁵,Yassin Aksam⁶⁷⁸

Affiliation:

1. Bremerhaven, Germany

2. Centre for Reproductive Medicine and Andrology / Clinical Andrology, University Clinics Muenster, Münster, Germany

3. Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, Massachusetts

4. Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany

5. Department of Urology and Uro-Oncology, Klinikum Braunschweig, Braunschweig, Germany

6. Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt, Germany

7. Dresden International University, Dresden, Germany

8. Department of Urology, Gulf Medical University, Ajman, United Arab Emirates

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes;Hackett;J Sex Med,2013

2. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss;Saad;Obesity,2013

3. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study;Traish;Int J Clin Pract,2014

4. Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome;Francomano;Int J Endocrinol,2014

5. Diagnosing and treating testosterone deficiency in different parts of the world: changes between 2006 and 2010;Gooren;Aging Male,2012

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent;European Urology;2024-08

2. Evaluating the impact of pre‐diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone‐related cancers: Surveillance, Epidemiology, and End Results‐Medicare 2007–2015;Andrology;2024-02-29

3. The effect of the discrepancy between pre- and post-operative staging on decision-making and quality of life in men undergoing a radical prostatectomy;Journal of Men's Health;2023

4. Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy”;Asian Journal of Andrology;2023

5. Testosterone Therapy: Injectable Androgens;Testosterone;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3